Compile Data Set for Download or QSAR
Report error Found 299 of affinity data for UniProtKB/TrEMBL: Q8WYB5
TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580699(US11492346, Example 39)
Affinity DataKi:  0.260nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580701(US11492346, Example 41)
Affinity DataKi:  0.360nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580669(US11492346, Example 9 | US11492346, Example 90 | U...)
Affinity DataKi:  0.420nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580702(US11492346, Example 42)
Affinity DataKi:  0.480nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580675(US11492346, Example 15)
Affinity DataKi:  0.600nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580661(US11492346, Example 1)
Affinity DataKi:  0.680nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM662989(Synthesis of N-(5-((1H-pyrazol-1-yl)methyl)-3,4-di...)
Affinity DataIC50: 0.700nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580683(US11492346, Example 23)
Affinity DataKi:  0.870nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580691(US11492346, Example 31)
Affinity DataKi:  0.890nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580678(US11492346, Example 18)
Affinity DataKi:  0.960nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580710(US11492346, Example 50)
Affinity DataKi:  0.980nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580674(US11492346, Example 14)
Affinity DataKi:  1.05nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM662985(Synthesis of 7-chloro-1-(2-chlorophenyl)-4-(prop-2...)
Affinity DataIC50: 1.10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580661(US11492346, Example 1)
Affinity DataKi:  1.14nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580681(US11492346, Example 21)
Affinity DataKi:  1.14nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580783(US11492346, Example 128)
Affinity DataKi:  1.20nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580751(US11492346, Example 93)
Affinity DataKi:  1.20nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580677(US11492346, Example 17)
Affinity DataKi:  1.21nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580669(US11492346, Example 9 | US11492346, Example 90 | U...)
Affinity DataKi:  1.23nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580669(US11492346, Example 9 | US11492346, Example 90 | U...)
Affinity DataKi:  1.30nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580707(US11492346, Example 47)
Affinity DataKi:  1.32nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580683(US11492346, Example 23)
Affinity DataKi:  1.34nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580733(US11492346, Example 73)
Affinity DataKi:  1.36nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580669(US11492346, Example 9 | US11492346, Example 90 | U...)
Affinity DataKi:  1.38nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580689(US11492346, Example 29)
Affinity DataKi:  1.40nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM662990(Synthesis of N-(5-((1H-pyrazol-1-yl)methyl)-3,4-di...)
Affinity DataIC50: 1.40nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM739492(N-(4-((1H-pyrazol-1-yl)methyl)-2,2-difluoro-[1,3]d...)
Affinity DataIC50: 1.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/9/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580669(US11492346, Example 9 | US11492346, Example 90 | U...)
Affinity DataKi:  1.55nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580705(US11492346, Example 45)
Affinity DataKi:  1.55nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580721(US11492346, Example 61)
Affinity DataKi:  1.56nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580669(US11492346, Example 9 | US11492346, Example 90 | U...)
Affinity DataKi:  1.63nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580676(US11492346, Example 16)
Affinity DataKi:  1.73nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B [431-2073](Homo sapiens (Human))
Bayer Aktiengesellschaft; The Broad Institute, Inc.

US Patent
LigandPNGBDBM757557(6-(Dimethylamino)-N-((2-methylquinolin-8-yl)sulfon...)
Affinity DataIC50: 1.78nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/28/2025
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580680(US11492346, Example 20)
Affinity DataKi:  1.78nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580672(US11492346, Example 12)
Affinity DataKi:  1.88nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580684(US11492346, Example 24)
Affinity DataKi:  1.89nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580730(US11492346, Example 70)
Affinity DataKi:  1.90nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580769(US11492346, Example 114)
Affinity DataKi:  2nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580692(US11492346, Example 32)
Affinity DataKi:  2.10nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580705(US11492346, Example 45)
Affinity DataKi:  2.11nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580672(US11492346, Example 12)
Affinity DataKi:  2.14nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580670(US11492346, Example 10)
Affinity DataKi:  2.27nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580751(US11492346, Example 93)
Affinity DataKi:  2.33nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580687(US11492346, Example 27)
Affinity DataKi:  2.39nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580666(US11492346, Example 6 | US11492346, Example 13)
Affinity DataKi:  2.5nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580752(US11492346, Example 94)
Affinity DataKi:  2.5nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580665(US11492346, Example 5)
Affinity DataKi:  2.68nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580750(US11492346, Example 92)
Affinity DataKi:  2.73nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580755(US11492346, Example 97)
Affinity DataKi:  2.74nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

TargetHistone acetyltransferase KAT6B(Human)
Pfizer

US Patent
LigandPNGBDBM580731(US11492346, Example 71)
Affinity DataKi:  2.81nMAssay Description:A. Compound preparation 1. Prepare 10 mM stock solutions in 100% DMSO from solid material 2. Serial dilute 10 mM, 1 mM or 0.1 mM compound stocks 3-fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/20/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 299 total ) | Next | Last >>
Jump to: